Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL30618995

O=C(O)C(F)(F)F.c1ncc(OC2CC2)c(N2CCNCC2)n1

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ CLK4 Q9HAZ1 1/20 0.40
▸ GPR6 P46095 15/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ HRH4 Q9H3N8 1/20 0.36
▸ PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL26599430 1.00 CYP2D6 (0.40) CYP2D6TSHRCLK4GPR6MEN1
SCHEMBL26669581 0.88 CYP1A2 (0.46) CYP2D6TSHRCLK4MEN1CYP1A2
Trifluoroacetic Acid SCHEMBL26600211 0.85 PKM (0.48) CYP2D6TSHRCLK4MEN1CYP1A2
Trifluoroacetic Acid SCHEMBL26599587 0.82 EPHX2 (0.50) GPR6HRH4
Trifluoroacetic Acid SCHEMBL30619105 0.80 CYP2D6 (0.42) CYP2D6TSHRCLK4MEN1CYP1A2
Trifluoroacetic Acid SCHEMBL26600638 0.80 CYP2D6 (0.42) CYP2D6TSHRCLK4MEN1CYP1A2
Trifluoroacetic Acid SCHEMBL2421451 0.78 CYP2D6 (0.45) CYP2D6TSHRCLK4MEN1CYP1A2
Trifluoroacetic Acid SCHEMBL30619066 0.73 KDM4E (0.39) CLK4PKM
SCHEMBL26669585 0.73 GPR119 (0.48) —
SCHEMBL27665814 0.72 CYP2D6 (0.49) CYP2D6TSHRCLK4MEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023205801-A2 STEROIDAL COMPOSITIONS AND METHODS OF TREATING LIPOGENIC CANCERS Asteroid Therapeutics (US) 2023-10-26 — — WO disclosed
Send feedback